These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19020411)

  • 1. Selective dopamine D4 receptor agonist (A-412997) improves cognitive performance and stimulates motor activity without influencing reward-related behaviour in rat.
    Woolley ML; Waters KA; Reavill C; Bull S; Lacroix LP; Martyn AJ; Hutcheson DM; Valerio E; Bate S; Jones DN; Dawson LA
    Behav Pharmacol; 2008 Dec; 19(8):765-76. PubMed ID: 19020411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A-412997, a selective dopamine D4 agonist, improves cognitive performance in rats.
    Browman KE; Curzon P; Pan JB; Molesky AL; Komater VA; Decker MW; Brioni JD; Moreland RB; Fox GB
    Pharmacol Biochem Behav; 2005 Sep; 82(1):148-55. PubMed ID: 16154186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-745,870, a subtype selective dopamine D4 receptor antagonist, does not exhibit a neuroleptic-like profile in rodent behavioral tests.
    Bristow LJ; Collinson N; Cook GP; Curtis N; Freedman SB; Kulagowski JJ; Leeson PD; Patel S; Ragan CI; Ridgill M; Saywell KL; Tricklebank MD
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1256-63. PubMed ID: 9400001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PIP3EA and PD-168077, two selective dopamine D4 receptor agonists, induce penile erection in male rats: site and mechanism of action in the brain.
    Melis MR; Succu S; Sanna F; Melis T; Mascia MS; Enguehard-Gueiffier C; Hubner H; Gmeiner P; Gueiffier A; Argiolas A
    Eur J Neurosci; 2006 Oct; 24(7):2021-30. PubMed ID: 17067298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A-412997 is a selective dopamine D4 receptor agonist in rats.
    Moreland RB; Patel M; Hsieh GC; Wetter JM; Marsh K; Brioni JD
    Pharmacol Biochem Behav; 2005 Sep; 82(1):140-7. PubMed ID: 16153699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine D4 receptor stimulation in GABAergic projections of the globus pallidus to the reticular thalamic nucleus and the substantia nigra reticulata of the rat decreases locomotor activity.
    Erlij D; Acosta-García J; Rojas-Márquez M; González-Hernández B; Escartín-Perez E; Aceves J; Florán B
    Neuropharmacology; 2012 Feb; 62(2):1111-8. PubMed ID: 22108379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A sensitizing regimen of amphetamine impairs visual attention in the 5-choice serial reaction time test: reversal by a D1 receptor agonist injected into the medial prefrontal cortex.
    Fletcher PJ; Tenn CC; Sinyard J; Rizos Z; Kapur S
    Neuropsychopharmacology; 2007 May; 32(5):1122-32. PubMed ID: 17047670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function.
    Berridge CW; Devilbiss DM; Andrzejewski ME; Arnsten AF; Kelley AE; Schmeichel B; Hamilton C; Spencer RC
    Biol Psychiatry; 2006 Nov; 60(10):1111-20. PubMed ID: 16806100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo occupancy of dopamine D3 receptors by antagonists produces neurochemical and behavioral effects of potential relevance to attention-deficit-hyperactivity disorder.
    Barth V; Need AB; Tzavara ET; Giros B; Overshiner C; Gleason SD; Wade M; Johansson AM; Perry K; Nomikos GG; Witkin JM
    J Pharmacol Exp Ther; 2013 Feb; 344(2):501-10. PubMed ID: 23197772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the D(3) dopamine receptor antagonist, U99194A, on brain stimulation and d-amphetamine reward, motor activity, and c-fos expression in ad libitum fed and food-restricted rats.
    Carr KD; Yamamoto N; Omura M; Cabeza de Vaca S; Krahne L
    Psychopharmacology (Berl); 2002 Aug; 163(1):76-84. PubMed ID: 12185403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of dopamine-dependent rewarding and locomotor stimulant effects of intravenously-administered methylphenidate in rats.
    Sellings LH; McQuade LE; Clarke PB
    Neuroscience; 2006 Sep; 141(3):1457-68. PubMed ID: 16753267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dopamine D4 receptor-selective antagonists on motor hyperactivity in rats with neonatal 6-hydroxydopamine lesions.
    Zhang K; Davids E; Tarazi FI; Baldessarini RJ
    Psychopharmacology (Berl); 2002 Apr; 161(1):100-6. PubMed ID: 11967637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conditioned place preference and locomotor activity in response to methylphenidate, amphetamine and cocaine in mice lacking dopamine D4 receptors.
    Thanos PK; Bermeo C; Rubinstein M; Suchland KL; Wang GJ; Grandy DK; Volkow ND
    J Psychopharmacol; 2010 Jun; 24(6):897-904. PubMed ID: 19282420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in the neurochemical and behavioural profiles of lisdexamfetamine methylphenidate and modafinil revealed by simultaneous dual-probe microdialysis and locomotor activity measurements in freely-moving rats.
    Rowley HL; Kulkarni RS; Gosden J; Brammer RJ; Hackett D; Heal DJ
    J Psychopharmacol; 2014 Mar; 28(3):254-69. PubMed ID: 24327450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of serotonin 2A receptors in the D-amphetamine-induced release of dopamine: comparison with previous data on alpha1b-adrenergic receptors.
    Auclair A; Blanc G; Glowinski J; Tassin JP
    J Neurochem; 2004 Oct; 91(2):318-26. PubMed ID: 15447665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral and neurophysiological effects of Ro 10-5824, a dopamine D4 receptor partial agonist, in common marmosets.
    Nakazawa S; Murai T; Miyauchi M; Kotani M; Ikeda K
    Psychopharmacology (Berl); 2015 Sep; 232(17):3287-95. PubMed ID: 26041337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin A deficiency induces motor impairments and striatal cholinergic dysfunction in rats.
    Carta M; Stancampiano R; Tronci E; Collu M; Usiello A; Morelli M; Fadda F
    Neuroscience; 2006; 139(4):1163-72. PubMed ID: 16530976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurochemical arguments for the use of dopamine D
    Huang M; Kwon S; He W; Meltzer HY
    Pharmacol Biochem Behav; 2017 Jun; 157():16-23. PubMed ID: 28455126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine D4 receptors inhibit depolarization-induced [3H]GABA release in the rat subthalamic nucleus.
    Floran B; Floran L; Erlij D; Aceves J
    Eur J Pharmacol; 2004 Sep; 498(1-3):97-102. PubMed ID: 15363981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A selective dopamine reuptake inhibitor improves prefrontal cortex-dependent cognitive function: potential relevance to attention deficit hyperactivity disorder.
    Schmeichel BE; Zemlan FP; Berridge CW
    Neuropharmacology; 2013 Jan; 64(1):321-8. PubMed ID: 22796428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.